A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol

INTRODUCTION: The classical pathway for the diagnosis of prostate cancer is transrectal ultrasound-guided (TRUS) biopsy of the prostate initiated on the basis of a raised prostate-specific antigen (PSA). An alternative pathway is to perform multi-parametricMRI (MPMRI) to localise cancer and to use t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasivisvanathan, Veeru, Jichi, Fatima, Klotz, Laurence, Villers, Arnauld, Taneja, Samir S, Punwani, Shonit, Freeman, Alex, Emberton, Mark, Moore, Caroline M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706484/
https://www.ncbi.nlm.nih.gov/pubmed/29025845
http://dx.doi.org/10.1136/bmjopen-2017-017863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706484/
https://www.ncbi.nlm.nih.gov/pubmed/29025845
http://dx.doi.org/10.1136/bmjopen-2017-017863

Ejemplares similares